Physician profile
William Eugene Olson
NPI 1457328502
$4,966.91
in general payments reported to CMS, 2019-2025
13 companies · $453 in 2025
The $453 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,028 · 2020: $78.34 · 2021: $284 · 2022: $429 · 2023: $464 · 2024: $231 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,148.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $2,093.65 | 2019-2023 | Alif |
| Medtronic USA, INC. | $880.61 | 2019 | |
| Bard Peripheral Vascular, INC. | $569.10 | 2021-2024 | Venclose Maven Catheter |
| Globus Medical, INC. | $506.52 | 2024-2025 | Alif, Xlif |
| Convatec INC. | $269.85 | 2023-2024 | |
| Medtronic, INC. | $252.71 | 2021-2025 | Venaseal |
| Boston Scientific Corporation | $154.03 | 2022-2024 | Varithena Administration Pack |
| Medtronic Vascular, INC. | $147.71 | 2019-2020 | |
| Venclose INC. | $28.62 | 2019 | |
| Becton, Dickinson and Company | $17.18 | 2025 | Venclose Maven Catheter |
| Tactile Systems Technology INC | $16.83 | 2021 | |
| Biocompatibles, INC. | $16.42 | 2019 | |
| Medline Industries Lp | $13.68 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.